Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914475-06-000006
Filing Date
2006-01-23
Accepted
2006-01-23 20:15:00
Documents
1
Period of Report
2006-01-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6567
  Complete submission text file 0000914475-06-000006.txt   8620
Mailing Address 12790 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Issuer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 12790 EL CAMINO REAL C/O NEUROCRINE BIOSCIENCES SAN DIEGO CA 92130
Business Address C/O ONYX PHARMECEUTICALS INC 3031 RESEARCH DR BLDG A RICHMOND CA 94806 8586177600
WIERENGA WENDALL (Reporting) CIK: 0001235945 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22705 | Film No.: 06544795